Bedford Group Transearch Life Sciences would like to congratulate Theresa Firestone on her appointment to the Board of Cybin (NYSE: CYBN).
Firestone joins the Board following a distinguished career as a senior healthcare executive with leadership positions in Canada, Europe and Asia. An expert in strategic planning, operations and new business development, her experience includes 20+ years of international P&L management, 15 years in senior roles at Pfizer (including 3 years as Regional President for Asia Emerging Markets)., over ten years at the Ontario Ministry of Health and seven years in retail and health and wellness, including Shoppers Drug Mart where she oversaw the design and launch of the company’s Medical Cannabis business. In addition, Ms. Firestone has more than 20 years of public and private board experience including with Orion Biotechnology, Merus Labs International and several not-for-profit organizations.
A link to the full release can be found here.
